MarketScreener Strategies Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 24/07/2026 +04			After hours 03:56:18
473.09 ^USD	+0.11%		488.29	+3.21%

07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT
07-20	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT

	Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease	December 11, 2023 at 02:47 pm
	Vertex Pharmaceuticals Incorporated : Confirms growth trajectory	May 04, 2023 at 05:35 pm
	Vertex Pharmaceuticals : A very promising pipeline	January 11, 2023 at 02:20 pm